期刊文献+

慢性肾脏病Ⅲ期患者甲状旁腺激素与左心室结构和功能的关系 被引量:5

The relationship between increased serum parathyroid hormone and left ventricular hypertrophy and dysfunction in patients with chronic renal disease Ⅲ
下载PDF
导出
摘要 目的:探讨慢性肾脏病Ⅲ期(CKD3)患者甲状旁腺激素(PTH)与心脏结构和功能变化特征的关系。方法:对60例CKD3期患者行心脏超声检查及血PTH检测.观察CKD3期患者PTH对心脏结构及功能改变特征的影响。结果:36.7%CKD3期患者有左室肥厚(LVH),其中54.5%为偏心性肥厚,45.5%为向心性肥厚,心功能损害以左心舒张功能受累为主(75.0%),并出现早。34例(56.7%)血PTH增高.且与左室后壁厚度(LVP-WT)、室间隔厚度(IVST)及左室心肌重量指数(LVMI)呈正相关,与舒张早期和舒张晚期最大血流速度比(E/A)呈负相关,与射血分数(EF)无关。结论:CKD3期时血PTH对心脏功能和结构的变化有一定的影响。 Objective: To observe the cardiac structure and function change in patients with chronic kidney disease 3 (CKD3), and the impact of parathyroid hormone (PTH) to all of the above. Method: In this study, echocardiography was performed and serum PTH level was determined in 60 patients with CKD3. To investigate the association between increased serum PTH and left ventricular hypertrophy(LVH)and dysfunction. Results: The overall prevalence of LVH was 36.7%, with eccentric LVH found in 54.5%, centripetal I.VH in 45.5 %. In this series left ventricular diastolic dysfunction occurred in 75 % and systolic dysfunction in 8.3%. Increased serum levels of PTH were found in 56. 7% of these patients, and PTH level was found significantly positively-correlated to LVPW, IVST and LVMI and negatively-correlated to left ventricular diastolic function (E/A). Conclusion: This study supports that the increasing serum PTH has certain effect to the cardiac structure and function changes in CKD3 patients.
作者 逯霞 桑晓红
出处 《新疆医科大学学报》 CAS 2009年第10期1456-1458,共3页 Journal of Xinjiang Medical University
关键词 慢性肾脏病Ⅲ期 心血管并发症 甲状旁腺激素 CKD3 cardiovascular complications parathyroid hormone
  • 相关文献

参考文献9

  • 1侯凡凡,马志刚,梅长林,戎殳,黄颂敏,刘先蓉,袁伟杰,郭云珊,王莉,何强,王秀玲,桑晓红,栗霄立.中国五省市自治区慢性肾脏病患者心血管疾病的患病率调查[J].中华医学杂志,2005,85(7):458-463. 被引量:182
  • 2Boyer JK,Thanigara JS,Schechtman KB, et al. Prevalence of ventricular diastolic dysfunction inasymptomatic, normotensive patients with diabetes mellitus[J]. Am J Cardiol, 2004,93 (7): 870-875.
  • 3Chs RN,Valensi P, Lormeau B, et al. Determinants of echocardio-graphically measured I.VM in diabetic patients with or without silent my-ocardial ischaemia [J]. Diabetes Metab, 1999,25(2) :128.
  • 4杜国庆,薛竞宜.实用临床超声心动图[M].沈阳:辽宁科学技术出版社.2005:124-125.
  • 5Wizenmann V,Schafer AD,Kramer W,et al. Follow up of cardiac chang induced by anemia compension in nomotensive hemodialysis patients with left ventricular hypertrophy [ J]. Nephrol,1993,64(2) :202.
  • 6Cannella G,Paoletti E. Myocardial hypertrophy in chronic renal failure: A multifactorial, reversible alteration [J]. Contrib Nephrol, 1996,119: 135.
  • 7陆慧勤,汪克定,陈强,王皓,邵伯良,计文明.PTH对尿毒症患者心脏结构和功能的影响[J].苏州大学学报(医学版),2005,25(4):668-669. 被引量:11
  • 8Manjunath G, Tighiouart H, Ibrahim H, et al. Level of kidney function as a risk factor for atherosclerotic cardiovascular disease in the community[J]. J Am Coll Cardiol, 2003, 41: 47-55.
  • 9Cheol WP, Yong SO, Young SS, et al. Infro venous calcitnd regresses myocardial hypertrophy in hemodialysis patient with secondary hyperparathy roidism[J]. Am J Kid Dis, 1999,33 (1):73.

二级参考文献25

  • 1侯凡凡.慢性肾脏病的心血管并发症[J].中华心血管病杂志,2004,32:16-16.
  • 2何长民 张训 见:何长民 张训主编.前言[A].见:何长民,张训主编.肾脏替代治疗学[C].上海:上海科学技术文献出版社,1999.2..
  • 3Locatelli F, Pozzoni P, Tentori F, et al. Epidemiology of cardiovascular risk in patients with chronic kidney disease. Nephrol Dial Transplant, 2003,18 Suppl 7:2-9.
  • 4Muntner P, He J, Hamm L, et al. Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. J Am Soc Nephrol, 2002,13:745-753.
  • 5Manjunath G, Tighiouart H, Ibrahim H, et al. Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. J Am Coll Cardiol, 2003,41:47-55.
  • 6Foley RN, Parfrey PS, Harnett JD, et al. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int, 1995,47:186-192.
  • 7Sarnak MJ, Levey AS, Schoolwerth AC,et al. Kidney disease as a risk factor for development of cardiovascular disease. A statement from the American Heart Association Councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Circulation, 2003,108:2154-2169.
  • 8Foley RN, Herzog CA, Collins AJ. Smoking and cardiovascular outcomes in dialysis patients: the United States Renal Data System Wave 2 Study. Kidney Int, 2003,63:1462-1467.
  • 9Wong JS, Rort FK, Hulbert-Shearon TE, et al. Survival advantage in Asian American end-stage renal disease patients. Kidney Int, 1999,55:2515-2523.
  • 10Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis, 1998,32:s112-s119.

共引文献191

同被引文献25

引证文献5

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部